Invitrogen™ Human TMEM184B Synthetic Peptide

Ref.: BL-RE-176275Manufacturer ref.: PEP-1046 50 μg
€149.00 excl. VAT

TMEM184B Synthetic Peptide, PEP-1046, from Invitrogen.

Gene ID (Enter)
25829
Species
Human
Purification method
Purified
Accession number
Q9Y519
Common name
Human TMEM184B
Brand
Invitrogen

TMEM184B Synthetic Peptide, PEP-1046, from Invitrogen.

TMEM184B Synthetic Peptide, PEP-1046, from Invitrogen.

TMEM184B, also known as C22orf5, is a 407 amino acid multi-pass membrane protein and represents a novel gene in the activation of the MAPK signaling pathway. The gene encoding TMEM184B maps to human chromosome 22; mutations in several of the genes in chromosome 22 are involved in the development of autism, schizophrenia, Phelan-McDermid syndrome and Neurofibromatosis type 2, suggesting that TMEM184B may play a role in these syndromes.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15235049
Specifications
Gene ID (Enter)25829
SpeciesHuman
Purification methodPurified
Accession numberQ9Y519
Common nameHuman TMEM184B
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TMEM184B
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1046
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.